Platelet binding characteristics distinguish placebo responders from nonresponders in depression

Neuropsychopharmacology

Volumn 12, Issue 4, 1995, Pages 315-322

  Sheline, Yvette I ^a   Black, Kevin J ^a   Bardgett, Mark E ^a   Csemansky, John G ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

5 HT uptake; 5 HTz receptor; Depression; Placebo; Serotonin

Indexed keywords

PLACEBO; SEROTONIN 2 RECEPTOR;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DEPRESSION; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; SEROTONIN UPTAKE; THROMBOCYTE;

ADULT; BIOLOGICAL MARKERS; BLOOD PLATELETS; DEPRESSIVE DISORDER; FEMALE; HUMAN; IODINE RADIOISOTOPES; LYSERGIC ACID DIETHYLAMIDE; MALE; PAROXETINE; PLACEBOS; PSYCHIATRIC STATUS RATING SCALES; RECEPTORS, SEROTONIN; REGRESSION ANALYSIS;

EID: 0029153529     PISSN: 0893133X     EISSN: 1740634X     Source Type: Journal    
DOI: 10.1016/0893-133X(94)00097-J     Document Type: Article

References (33)

1. Arora RC, Meltzer HY (1989): Increased serotonin 2 (5-HT2) receptor binding as measured by 3H-lysergic acid diethylamide (3H-LSD) in the blood platelets of depressed patients. Life Sci 44:725-734
2. Biegon A, Grinspoon A, Blumenfeld B, Bleich A, Apter A, Mester R (1990): Increased serotonin 5-HT2 receptor binding on blood platelets of suicidal men. Psychophar- macol 100:165-167
3. Brown WA, Dornseif BE, Wernicke JF (1988): Placebo response in depression: A search for predictors. Psychiatr Res 26:259-264
4. Brown WA, Johnson MF, Chen M-G (1992): Clinical features of depressed patients who do and do not improve with placebo. Psychiatr Res 41:203-214
5. Bunney WE, Garland-Bunney B, Patel SB (1986): Biological markers in depression. Psychopathology 19(2):72-78
6. 2a receptor. J Neurochem 63:465-469
7. Fairchild CJ, Rush AJ, Vasavada N, Giles DE, Khatami M (1986): Which depressions respond to placebo? Psychiatr Res 18:217-226
8. Faustmann WO, Faull KF, Whiteford HW, Bochert C, Cser- nansky JG (1990): CSF 5-HIAA, serum cortisol and age differentially predict vegetative and cognitive symptoms in depression. Biol Psychiatr 27:311-318
9. Freeman AM, Stankovic SMI, Bradley RJ, Zhang GZ, Libb JW, Nemeroff CB (1993): Tritiated platelet imipramine binding and treatment response in depressed outpatients. Depression 1:20-23
10. Gross-Isseroff R, Israel M, Biegon A (1989): Autoradiographic analysis of tritiated imipramine binding in the human brain post-mortem: Effects of suicide. Arch Gen Psychiatry 46:237-241
11. Grunbaum A (1985): Explication and implications of the placebo concept. In White L, Tursky B, Schwartz G (eds), Placebo: Theory, Research and Mechanisms, New York, Guilford Press, p 9
12. Hamilton M (1960): A rating scale for depression. J Neurol Neurosurg Psychiatry 23:56-62
13. Khan A, Dager SR, Cohen S, Avery DH, Scherzo SA, Dünner DC (1991): Chronicity of depressive episode in relation to antidepressant-placebo response. Neuropsy- chopharmacol 4:125-130
14. Lesch K-P, Wolozin BL, Murphy DL, Riederer P (1993): Primary structure of the human platelet serotonin uptake site: Identity with the brain transporter. J Neurochem 60:2319-2322
15. Mann JJ, McBride PA, Brown RP, et al. (1992): Relationship between central and peripheral serotonin indexes in depressed and suicidal psychiatric inpatients. Arch Gen Psych 49:442-446
16. Marcusson J, Ross SB (1990): Binding of some antidepressants to the 5-hydroxytryptamine transporter in brain and platelets. Psychopharmacol 102:145-155
17. Meltzer HY, Arora RC (1988): Genetic control of serotonin uptake in blood platelets: A twin study. Psychiatr Res 24:263-269
18. Meltzer HY, Lowy MT (1987): The serotonin hypothesis of depression. In Meltzer HY (ed), Psychopharmacology, The Third Generation of Progress, New York, Raven, pp 513-526
19. Montgomery SA, Asberg M (1979): A new depression rating scale designed to be sensitive to change. Br J Psychiatry 134:382-389
20. Pandey GN, Pandey SC, Janicak PG, Merks RC, Davis JM (1990): Platelet serotonin-2 receptor binding sites in depression and suicide. Biol Psychiatry 28:215-222
21. Peselow E, Sanfilipo M, Difiglia C, Fieve R (1992): Melan- cholic/endogenous depression and response to somatic treatment and placebo. Am J Psychiatry 149:1324-1334
22. Quitkin FM, Rabkin J, Ross D (1984): Identification of a true drug response to antidepressants: Use of pattern analysis. Arch Gen Psychiatry 41:782-786
23. Quitkin FM, Rabkin JG, Stewart JW, McGrath PJ, Harrison W, Ross DC, Tricamo E, Fleiss J, Markowitz J, Klein DT (1991): Heterogeneity of clinical response during placebo treatment. Am J Psychiatry 148:193-196
24. Quitkin FM, Stewart JW, McGrath PJ, Nunes E, Ocepek- Welikson K, Tricamo E, Rabkin JG, Ross D, Klein DF (1993a): Loss of drug effects during continuation therapy. Am J Psychiatry 150:562-565
25. Quitkin FM, Stewart JW, McGrath PJ, Nunes E, Ocepek- Welikson K, Tricamo E, Rabkin JG, Ross D, Klein DF (1993b): Further evidence that a placebo response to antidepressants can be identified. Am J Psychiatry 150: 566-570
26. Rabkin JG, Stewart JW, McGrath PJ, Markowitz JS, Harrison W, Quitkin FM (1987): Baseline characteristics of 10-day placebo washout responders in antidepressant trials. Psychiatr Res 21:9-22
27. Ramamoorthy S, Bauman AL, Moore KR, Han H, Yang-Feng, Chang AS, Ganapathy V, Blakely RD (1993): Antidepressant and cocaine-sensitive human serotonin transporter: Molecular cloning, expression, and chromosomal localization. Proc Natl Acad Sci USA 90:2542-2546
28. Shapiro AK, Morris L (1978): The placebo effect in medical and psychological therapies. In Garfield S, Bergen A (eds), Handbook of Psychotherapy and Behavior Change, ed 2, New York, Wiley, p 369
29. Sheline YI, Bardgett ME, Jackson JL, Newcomer JW, Cser- nansky JG (1995): Platelet serotonin markers and depressive symptomatology. Biol Psychiatry 37:442-447
30. Stanley M, Virgilio J, Gershon S (1982): Tritiated imipramine binding sites are decreased in the frontal cortex of suicides. Science 216:1337-1339
31. Trivedi MH, Rush J (1994): Does a placebo run-in or a placebo treatment cell affect the efficacy of antidepressant medications? Neuropsychopharmacol 11:33-43
32. Turner J, Gallimore R, Fox-Henning C (1980): An annotated bibliography of placebo research. JS AS Catalog of selected documents in Psychology 10 no. 2063
33. Zammit GK, Rosenbaum AH, Stokes P, Davis J, Zorick F, Roth T (1988): Biological differences in endogenous depressive placebo responders versus nonresponders: Dexamethasone suppression test and sleep EEG data. Biol Psychiatry 24:97-101